Sarcopenia was independently associated with incident depressive symptoms in Chinese adults aged 45 and older, but sleep duration did not significantly mediate this association after covariate adjustment.
Key Findings
Results
Over 4 years of follow-up, 27.72% of participants without baseline depressive symptoms developed incident depressive symptoms.
The prospective cohort used China Health and Retirement Longitudinal Study (CHARLS) data from 2011 to 2015.
5346 participants aged 45 years and older without baseline depressive symptoms were included.
1482 participants (27.72%) developed incident depressive symptoms.
Depressive symptoms were assessed with the 10-item CES-D, with a cutoff of ≥10 indicating depression.
Results
Possible sarcopenia was significantly associated with an increased risk of incident depressive symptoms after adjusting for confounders.
Adjusted hazard ratio (HR) = 1.21, 95% CI: 1.02-1.44.
Sarcopenia was defined using the Asian Working Group for Sarcopenia 2019 criteria.
Analysis used Cox proportional hazards models.
Results
Confirmed sarcopenia was associated with a higher risk of incident depressive symptoms than possible sarcopenia.
Adjusted HR = 1.36, 95% CI: 1.04-1.78 for confirmed sarcopenia.
This compares with HR = 1.21 for possible sarcopenia, suggesting a graded pattern of risk by sarcopenia status.
Results
Longer sleep duration was independently associated with a lower risk of incident depressive symptoms.
HR = 0.93, 95% CI: 0.90-0.96.
Sleep duration was self-reported.
Restricted cubic spline regression was used to examine the dose-response relationship.
Results
Sleep duration did not significantly mediate the association between sarcopenia and incident depressive symptoms after covariate adjustment.
The mediating effect became non-significant after covariate adjustment (P = .302).
Bootstrap mediation analysis was employed.
The authors describe the findings as exploratory and to be interpreted cautiously.
Conclusions
The authors conclude that sarcopenia prevention and management may benefit mental well-being in aging populations.
Sarcopenia was independently associated with incident depressive symptoms.
The suggestion is based on observational, exploratory findings, so causality cannot be established.
What This Means
This study followed 5,346 Chinese adults aged 45 and older who did not have depressive symptoms at the start. Over four years, about 28% developed depressive symptoms. People with possible sarcopenia (age-related loss of muscle strength and mass) had about a 21% higher risk, and people with confirmed sarcopenia had about a 36% higher risk, compared with those without sarcopenia, after accounting for other factors.
The researchers also looked at sleep. Longer self-reported sleep was linked to a lower risk of depressive symptoms. However, sleep duration did not appear to explain the link between sarcopenia and depression once other factors were accounted for, so the connection between muscle loss and depression likely involves other pathways.
This research suggests that maintaining muscle health may be relevant to mental well-being in later life. Because this is an observational study using self-reported sleep and a symptom questionnaire rather than clinical diagnosis, it cannot show that sarcopenia causes depression, and the authors describe the mediation findings as exploratory.
Check Your Own Numbers
Upload your bloodwork. We'll cross-reference your results against this study and 4,700 others.
Jiang J, Zhou Q, Zhang C, Ma Y. (2026). Sleep duration, sarcopenia, and incident depressive symptoms in Chinese middle-aged and older adults: A prospective cohort study based on CHARLS.. Medicine. https://doi.org/10.1097/MD.0000000000051177